- Andrew, K. A., H. M. Simkins, S. Witzel, R. Perret, J. Hudson, I. F. Hermans, D. S. Ritchie, J. Yang and F. Ronchese (2008). "Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo." Journal of Immunology 181(12): 8356-8362.
- Arulogun, S., H. M. Prince, P. Gambell, S. Lade, G. Ryan, E. Eaton and C. McCormack (2008). "Extracorporeal photopheresis for the treatment of Sezary syndrome using a novel treatment protocol." Journal of the American Academy of Dermatology 59(4): 589-95.
- Bercovici, N., N. Haicheur, S. Massicard, F. Vernel-Pauillac, O. Adotevi, D. Landais, I. Gorin, C. Robert, H. M. Prince, J. J. Grob, M. T. Leccia, T. Lesimple, J. Wijdenes, J. Bartholeyns, W. H. Fridman, M. Salcedo, E. Ferries and E. Tartour (2008). "Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients." Journal of Immunotherapy 31(1): 101-12.
- Bishton, M. J., R. J. Hicks, H. M. Prince, D. S. Ritchie, M. Wolf and J. F. Seymour (2008). "Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set." Leukemia 22(12): 2259-60; author reply 2260-1.
- Ellis, L., Y. Pan, G. K. Smyth, D. J. George, C. McCormack, R. Williams-Truax, M. Mita, J. Beck, H. Burris, G. Ryan, P. Atadja, D. Butterfoss, M. Dugan, K. Culver, R. W. Johnstone and H. M. Prince (2008). "Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma." Clinical Cancer Research 14(14): 4500-4510.
- Flowers, M. E., J. F. Apperley, K. van Besien, A. Elmaagacli, A. Grigg, V. Reddy, A. Bacigalupo, H. J. Kolb, L. Bouzas, M. Michallet, H. M. Prince, R. Knobler, D. Parenti, J. Gallo and H. T. Greinix (2008). "A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease." Blood 112(7): 2667-74.
- Gill, S., A. Grigg, J. Szer and D. Ritchie (2008). "Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemia." Leukemia and Lymphoma 49(5): 896-901.
- Gill, S., S. W. Lane, J. Crawford, G. Cull, D. Joske, P. Marlton, P. N. Mollee, H. M. Prince and J. F. Seymour (2008). "Prolonged haematological toxicity from the hyper-CVAD regimen: manifestations, frequency, and natural history in a cohort of 125 consecutive patients." Annals of Hematology 87(9): 727-34.
- Gill, S. and D. Ritchie (2008). "Therapeutic options in mantle cell lymphoma." Leukemia and Lymphoma 49(3): 398-409.
- Gill, S., M. Wolf, H. M. Prince, H. Januszewicz, D. Ritchie, R. J. Hicks and J. F. Seymour (2008). "[18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma." Clinical Lymphoma and Myeloma 8(3): 159-65.
- Green, J., E. Upjohn, C. McCormack, J. Zeldis and H. M. Prince (2008). "Successful treatment of Behcet's disease with lenalidomide." British Journal of Dermatology 158(1): 197-8.
- Harrison, S. J., I. M. Franklin and J. D. Campbell (2008). "Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapy." Leukemia and Lymphoma 49(12): 2272-83.
- Herbert, K. E., J. P. Levesque, D. N. Haylock and H. M. Prince (2008). "The use of experimental murine models to assess novel agents of hematopoietic stem and progenitor cell mobilization." Biology of Blood and Marrow Transplantation 14(6): 603-21.
- Herst, P. M., E. L. Hesketh, D. S. Ritchie and M. V. Berridge (2008). "Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60rho(0) cells." Leukemia Research 32(2): 327-33.
- Hoyt, R., D. S. Ritchie, A. W. Roberts, L. Macgregor, D. J. Curtis, J. Szer and A. P. Grigg (2008). "Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants." Bone Marrow Transplant 41(7): 651-8.
- Morrissey, C. O., P. G. Bardy, M. A. Slavin, M. R. Ananda-Rajah, S. C. Chen, S. W. Kirsa, D. S. Ritchie and A. Upton (2008). "Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy." Internal Medicine Journal 38(6b): 477-95.
- Neeson, P., Z. K. Pan and Y. Paterson (2008). "Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma." Cancer Immunology, Immunotherapy 57(4): 493-505.
- Peinert, S., H. M. Prince and S. Harrison (2008). "The development of novel immunotherapeutic approaches in multiple myeloma." Leukemia and Lymphoma 49(4): 652-4.
- Prince, H. M., M. Bishton and S. Harrison (2008). "The potential of histone deacetylase inhibitors for the treatment of multiple myeloma." Leukemia and Lymphoma 49(3): 385-87.
- Prince, H. M., D. M. Wall, D. Ritchie, D. Honemann, S. Harrison, H. Quach, M. Thompson, R. Hicks, E. Lau, J. Davison, M. Loudovaris, J. Moloney, B. Loveland, J. Bartholeyns, A. Katsifis and L. Mileshkin (2008). "In vivo tracking of dendritic cells in patients with multiple myeloma." Journal of Immunotherapy 31(2): 166-79.
- Rischin, D. and A. Coleman (2008). "Sinonasal malignancies of neuroendocrine origin." Hematology/Oncology Clinics of North America 22(6): 1297-1316.
- Ritchie, D. S. (2008). "Is allogeneic stem cell transplantation for transformed follicular lymphoma anti-lymphoma stem cell therapy?" Leukemia and Lymphoma 49(10): 1852-3.
- Ritchie, D. S., M. McBean, D. A. Westerman, S. Kovalenko, J. F. Seymour and A. Dobrovic (2008). "Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib." Blood 111(5): 2896-8.
- Sutherland, J. S., L. Spyroglou, J. L. Muirhead, T. S. Heng, A. Prieto-Hinojosa, H. M. Prince, A. P. Chidgey, A. P. Schwarer and R. L. Boyd (2008). "Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade." Clinical Cancer Research 14(4): 1138-49.
- Westwood, J. A., W. K. Murray, M. Trivett, A. Shin, P. Neeson, D. P. MacGregor, N. M. Haynes, J. A. Trapani, P. Mayura-Guru, S. Fox, S. Peinert, D. Honemann, H. M. Prince, D. Ritchie, A. M. Scott, F. E. Smyth, M. J. Smyth, P. K. Darcy and M. H. Kershaw (2008). "Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice." Gene Therapy 15(14): 1056-66.
- Zhang, L., D. Lebwohl, E. Masson, G. Laird, M. R. Cooper and H. M. Prince (2008). "Clinically relevant QTc prolongation is not associated with current dose schedules of LBH589 (panobinostat)." Journal of Clinical Oncology 26(2): 332-3; discussion 333-4.
|
